14 Jul Report Underscores Importance of Universal COVID-19 Testing in Nursing Homes
It is critical to rapidly enact widespread testing so that positive cases can be identified and isolated before more transmission occurs....
It is critical to rapidly enact widespread testing so that positive cases can be identified and isolated before more transmission occurs....
Dr. Woolf[/caption]
Steven H. Woolf, MD, MPH
Center on Society and Health
Virginia Commonwealth University School of Medicine
Richmond
MedicalResearch.com: What is the background for this study?
Response: Our concern since the pandemic began was that lives would be lost not only to the virus but also to the ripple effects of how society responds to the crisis, such as reduced access to health care, extreme economic hardships, and psychological stress.
Eileen B. Leary[/caption]
Eileen B. Leary, Ph.D. Student
Epidemiology and Clinical Research
Stanford University
MedicalResearch.com: What is the background for this study? Would you briefly explain what is meant by REM sleep?
Response: Sleep is a regulated, reversible, and recurring loss of consciousness that is a critical requirement for a happy, healthy life. REM sleep is an important component of sleep defined by rapid eye movements and commonly associated with dreaming.
We learned from previous studies that sleep duration is associated with mortality, however little was known about how the different sleep stages relate to timing or cause of death.
Dr. Brantley[/caption]
Erin Brantley, PhD, MPH
Senior Research Associate
Department of Health Policy and Management
Milken Institute School of Public Health
Preferred pronouns: she/her/hers
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: We looked at what happened when work requirements for the Supplemental Nutrition Assistance Program Participation, or SNAP, were turned on in many places after the Great Recession.
We found large drops in participation in SNAP benefits due to work requirements, and that black recipients were more likely to lose benefits than white recipients. We think this is driven by the fact that black workers face higher unemployment rates than white workers, and work requirement policies do not take this into account.
We also found that some people who report having disabilities lost benefits, even though the intent of work requirements is that they apply to people without disabilities.
Example of Chilblains
Dr. Wong[/caption]
Robert Wong, MD, MS
Division of Gastroenterology and Hepatology
Veterans Affairs Palo Alto Healthcare System
Stanford University School of Medicine
MedicalResearch.com: What is the background for this study?
Response: Prior to this study, we already knew that obesity and metabolic syndrome were major public health issues in the U.S. A previous analyses by our team which analyzed data through 2012 observed than one in three adults in the U.S. have metabolic syndrome. The aim of our current study was to evaluate more recent trends in the prevalence of metabolic syndrome and to identify whether certain groups are at higher risk of having metabolic syndrome.
Dr. Cole Brahim[/caption]
Megan B. Cole Brahim, PhD, MPH
Assistant Professor | Dept. of Health Law, Policy, & Management
Boston University School of Public Health
Boston, MA
MedicalResearch.com: What is the background for this study?
Response: Enrollment in high deductible health plans (HDHPs)—which require patients to pay on the upwards of thousands of dollars in out-of-pocket costs before they can use their health insurance coverage for most services—has skyrocketed over the last decade. For cancer survivors in particular, this is really concerning, as patients may avoid or delay necessary health care services or important medications because they can’t afford their deductible. We know from previous work that HDHPs are associated with less use of health care, including less cancer screening and treatment. However, there has been very little work to assess how HDHPs may contribute to racial/ethnic disparities in care, and our study is the first known study to assess how HDHPs may contribute to racial/ethnic disparities in cancer survivors.
To fill this gap, we used nationally representative survey data from 2013-2018 to assess how enrollment in high deductible health plans was associated with cost-related barriers to care among cancer survivors with private insurance, and how this relationship varied across racial/ethnic groups.
Response: This study found that recreational cannabis laws were associated with increases in traffic fatalities in Colorado (mean of 75 excess fatalities per year) but not in Washington State. These findings suggest that unintended effects of recreational cannabis laws can be heterogeneous and may be specific to variations in how these laws are implemented
(eg, density of recreational cannabis stores).
Response: It is well known that marijuana usage impairs driving ability, yet the early studies of the effects of recreational marijuana legalization on traffic fatalities were inconclusive.
MedicalResearch.com: What are the main findings?
Response: By analyzing data over a longer time period, we found that the legalization of recreational marijuana increased traffic deaths in the first four states to legalize. Traffic fatalities increased about 20% in those states. If we apply these numbers to the nation as a whole, nationwide legalization would be associated with about 7,000 excess traffic fatalities each year.
Dr. Brown[/caption]
Chase Brown, MD
Associate Fellow, Leonard Davis Institute of Health Economics
Integrated Cardiac Surgery Resident
Hospital of the University of Pennsylvania
[caption id="attachment_54629" align="alignleft" width="111"]
Dr. Desai[/caption]
Nimesh D. Desai, MD, PhD
Director, Thoracic Aortic Surgery Research Program
Associate Professor of Surgery
Hospital of the University of Pennsylvania
MedicalResearch.com: What is the background for this study?
Dr. Chase Brown: Opioid use in the United States is a public health emergency. We know that opioids prescribed after general surgery operations to patients who never received them within the year prior to their surgery are at increased risk for continuing to take opioids months later. However, this has not been studied in patients undergoing cardiac surgery, who often times have more severe post-operative pain.
Our goal in this study was to determine how many patients after cardiac surgery and are opioid naive are continuing to take opioids within 90-180 days after their surgery.
Dr. Davidson[/caption]
Dr. Karina Davidson, PhD
Senior Vice President of Research
Dean of Academic Affairs
Professor of Behavioral Medicine
Zucker School of Medicine
Hofstra University/Northwell Health
Vice Chairmam
US Preventive Services Task Force
MedicalResearch.com: What is the background for this study?
Response: Drug use is among the most common causes of preventable death, injury, and disability in the United States, with nearly 10 percent of adults reporting unhealthy drug use. This includes the use of illegal drugs, as well as using prescription drugs in ways that are not recommended by a doctor.
Dr. Pratley[/caption]
Richard E. Pratley, MD
AdventHealth
Samuel E. Crockett Chair in Diabetes Research
Medical Director | AdventHealth Diabetes Institute
Senior Investigator and Diabetes Program Lead
AdventHealth Translational Research Institute
MedicalResearch.com: What is the background for this study?
Response: Historically, older individuals with T1D have been underrepresented or excluded from clinical trials. Older individuals with T1D are at particularly high risk for hypoglycemia. Because of their long duration of diabetes, they often have impaired counterregulatory responses and hypoglycemia unawareness. Hypoglycemia in older individuals is particularly dangerous because it can lead to falls and fractures, cognitive impairment and cardiovascular events, including death. There has been the misperception that older individuals are less able to use technology to manage their diabetes. This study dispelled that notion.
Prof. Constantinescu[/caption]
Cris S Constantinescu, MD, PhD, FRCP
Professor, Division of Clinical Neuroscience
Research Group in Clinical Neurology
University of Nottingham
Queen's Medical Centre
Nottingham UK
MedicalResearch.com: What is the background for this study?
Response: The study is in some way a test of the hygiene or old friends hypothesis, whereby eradication, through improved hygiene, of some parasites that have existed in the human gut for thousands of years and have suppressed inflammatory reactions, leads to an increase in inflammatory conditions. This has been used to explain the increased autoimmune and inflammatory diseases in the developed world.
Healthy volunteer studies at the University of Nottingham showed therapeutic hookworm infection to be safe and well tolerated up to about 50 larvae, and then safety studies in people with airway hyperreactivity and inflammatory bowel disease raised no concern. Following a study in Argentina showing that people with MS have milder disease when they have a natural co-existing asymptomatic infection with intestinal parasites, we (Professor Pritchard, immunoparasitologist and myself) decided to test hookworm in MS, and for the first time used 25 larvae in a patient study.
Dr. Sajadi[/caption]
Mohammad Sajadi, MD
Associate Professor
Institute of Human Virology
Global Virus Network Center of Excellence
University of Maryland School of Medicine
Baltimore, MD 21201
MedicalResearch.com: What is the background for this study?
Response: Because of geographical proximity and significant travel connections, epidemiological modeling of the epicenter predicted that regions in Southeast Asia, and specifically Bangkok would follow Wuhan, and China in the COVID-19 epidemic. When we saw this did not happen, we suspected that SARS-CoV-2 might be acting like a seasonal respiratory virus.
Tobias Kurth, MD, ScD (Pronouns: he/him)
Professor of Public Health and Epidemiology
Director, Institute of Public Health
Charité – Universitätsmedizin Berlin
MedicalResearch.com: What is the background for this study?
Response: Migraine (with aura) has been associated with increased risk of cardiovascular disease but its absolute contribution in relation to other major vascular risk factors was not unclear.
Dr. Travers[/caption]
Colm Travers, M.D., MSPH
Assistant Professor
Department of Pediatrics
University of Alabama at Birmingham
MedicalResearch.com: What is the background for this study?
Response: It is known that black mothers are much more likely to deliver preterm and low birth weight infants. The purpose of this study was to determine whether racial/ethnic disparities in care practices and outcomes were decreasing or increasing among extremely preterm infants.
These are infants born from 22 to 27 weeks of gestation who have a high risk of death and major illnesses.
Dr. Sood[/caption]
Manish M Sood MD FRCPC MSc
Jindal Research Chair for the Prevention of Kidney Disease
Associate Professor of Medicine, Dept. of Medicine and the School of Epidemiology and Public Health
University of Ottawa
Scientist, Ottawa Hospital Research Institute
Nephrologist, The Ottawa Hospital
Ottawa, Ontario, Canada
MedicalResearch.com: What is the background for this study?
Response: Early work has suggested a very commonly used antibiotic, clarithromycin, may interfere with the metabolism of the most widely used type of blood thinning medication (called direct oral anticoagulants or DOACs) such that the blood level of the DOAC increases and may place the patient at a higher risk for bleeding. In our study we looked at patients of advanced age (>66 years old) who were given clarithromycin while on a DOAC in Ontario, Canada. We compared patients on clairthromycin-DOAC to patients given a very similar antibiotic, azithromycin, that does not interfere with the metabolism of DOAC.
Dr. Kao-Ping Chua[/caption]
Kao-Ping Chua, M.D., Ph.D.
Assistant Professor, Pediatrics, Medical School
Susan B. Meister Child Health Evaluation and Research Center
University of Michigan
MedicalResearch.com: What is the background for this study?
Response: Due to high and rising prices, insulin has become increasingly unaffordable for patients with type 1 diabetes who must pay out-of-pocket for this life-saving medication. Over the past 5 months, many states and insurers have taken steps to cap insulin out-of-pocket spending. For example, Cigna imposed a $25 monthly cap earlier this year. This week, the Centers for Medicare and Medicare Services announced a $35 monthly cap for many Medicare Part D beneficiaries.
Katri Räikkönen
Professor, Department of Psychology and Logopedics
University of Helsinski
MedicalResearch.com: What is the background for this study?
Response: Maternal antenatal corticosteroid treatment is standard care when there is a risk for preterm delivery. The treatment improves the prognosis of babies born preterm.
In high-income countries, antenatal corticosteroid treatment has been in routine use for over 30 years. Recommendations and clinical care guidelines for maternal antenatal corticosteroid treatment differ between continents and countries. In Finland the treatment is currently recommended when the risk for preterm delivery is at 34 gestational weeks or less. In select cases, the treatment is recommended even later in gestation. Corticosteroids accelerate fetal maturation, especially in the lungs, and increase the child’s resilience to the stress that results from being born preterm.
However, antenatal corticosteroids not only cross the placenta, but also cross the the blood-brain barrier and may harm fetal brain development. We are not aware of previous population-based studies that would have tested if maternal antenatal corticosteroid treatment would be associated with mental and behavioral disorders in children and we are not either aware of studies that would have tested if any associations would be explained by shared genetic or familial factors.
Dr. Morichau-Beauchant[/caption]
Dr Tristan Morichau-Beauchant, MD.
Intensive Care Unit
Centre Cardiologique du Nord
Saint-Denis, France
MedicalResearch.com: What is the background for this study?
Response: During the spread of the COVID-19 epidemic in France, early reports on severe patients stated a highly increased inflammatory response associated with procoagulant changes in coagulation pathways and high D-Dimer levels. Preliminary reports from the intensive care community signaled frequent events of deep vein thrombosis (DVT) among this population. We decided to perform prospectively a venous ultrasonogram of the inferior limbs for all patients with severe COVID-19 pneumonia at admission in our ICU. All patients had acute respiratory distress syndrome according to the Berlin definition an required mechanical ventilation. Considering the high prevalence of venous thrombosis at admission we repeated a venous ultrasonography after 48 hours if the first exam was normal. All patients received standard anticoagulant prophylaxis since hospital admission.
Dr. Soumya Sen[/caption]
Soumya Sen PhD
McKnight Presidential Fellow
Mary & Jim Lawrence Fellow of Carlson School
Director of Research, MIS Research Center
Associate Professor, Information & Decision Sciences
Carlson School of Management
University of Minnesota, Minneapolis, MN
MedicalResearch.com: What is the background for this study?
Response: As the Covid-19 pandemic unfolded across the United States, one of the greatest barriers to understanding the extent of the problem was the lack of reliable and consistent data. Some of the metrics being reported, such as case count and death, are insufficient for hospital capacity planning. Case count is a conservative estimate of the actual number of infected individuals in the absence of community-wide serologic testing, while death count is a lagging metric and insufficient for proactive hospital capacity planning.
A more valuable metric for assessing the effects of public health interventions on the health care infrastructure is hospitalizations. Therefore, the Medical Industry Leadership Institute (MILI) and the Management Information Systems Research Center (MISRC) at the Carlson School of Management launched the COVID-19 hospitalization tracking project in March to consistently track and report daily hospitalizations from all reporting states. Tracking daily hospitalization data is a major step forward in quantifying the current impact on local hospital systems, modeling and forecasting future utilization needs, and tracking the rate of change in the disease severity. It is also useful for understanding the role of health policy interventions in slowing or reducing the impact of the pandemic.
Dr. Boffa[/caption]
Daniel J. Boffa, MD
Associate Professor of Thoracic Surgery
Yale School of Medicine
MedicalResearch.com: What is the background for this study?
Response: The study examined networks that formed around hospitals that had been previously ranked in the top-50 by US News and World Report. These top-ranked hospitals have shared their brand with hospitals in their network, which leads some people to believe that the care is the same at top-ranked hospitals and their affiliate hospitals. We wanted to determine if outcomes after complex surgical procedures were truly the same at affiliate hospitals and top-ranked hospitals.
Dr. Myers[/caption]
Sara P. Myers, M.D., Ph.D.
University of Pittsburgh School of Medicine
MedicalResearch.com: What is the background for this study?
Response: Compared to other fields, medicine, and especially academic surgery and its subspecialties, trail with respect to gender diversity. Considering that these fields were traditionally male-dominated, two issues that may present ongoing challenges to the retention and promotion of women are pro-male bias and negative stereotypes about women. Training specific to pursuing a surgical career begins in residency, so it is important to understand how these issues affect motivation and achievement during this formative period.
In our study we first evaluated the association between pro-male bias and research-related career engagement using a survey methodology, and then looked at whether evoking negative stereotypes about women was associated with reduced performance on a simulated technical skill assessment called the Fundamentals of Laparoscopic Surgery (FLS) assessment.
Dr. Cavanaugh[/caption]
Alyson Cavanaugh, PT, PhD
Joint Doctoral Program in Epidemiology
University of California, San Diego/ San Diego State University
MedicalResearch.com: What is the background for this study?
Response: More than 700,000 total knee replacements are performed annually in the United States, but there is a racial disparity in outcomes after the surgery. If the knee replacement procedure is considered a highly effective treatment, why don't black women present with the same outcomes as whites?
Physical function when going into surgery has a large impact on the potential functional outcomes after surgery. Our hypothesis was that black women were presenting to surgery with poorer physical function, which was contributing to poorer functional outcomes after surgery.
Dr. Van der Pol[/caption]
Barbara Van Der Pol, PhD, MPH
President, American STD Association
President-Elect, International Society fo STD Research
Professor of Medicine & Public Health
Director, STD Diagnostics Lab
Director, UAB STD Clinical Research Organization
University of Alabama at Birmingham
Birmingham, AL 35294
MedicalResearch.com: What is the background for this study?
Response: For many decades, public health programs focused on control and prevention of sexually transmitted infections (STI) have relied on lab based tests that required a 1-day to 1-week wait for test results. Efforts to shorten the duration of infection lead to treating at the time of the clinic visit based on the association between certain clinical signs or symptoms and the likelihood of infection.
Unfortunately, more than ½ of infected persons do not have signs or symptoms so they receive no treatment until test results are available. Thus, a test that could be performed at the clinical site with a limited wait time would improve the accuracy of treatment and shorten the duration of infection. Such a strategy will hopefully reduce the number of return clinic visits, the possibility of transmission, and the potential for consequences of untreated infection such as infertility.
Dr. Chambers[/caption]
James D. Chambers, PhD, MPharm, MSc
Associate Professor of Medicine
Tufts Medical Center Institute for Clinical Research and Health Policy Studies
MedicalResearch.com: What is the background for this study?
Response: We know that biosimilars have not had the same uptake in the US as they have had elsewhere. We know that this is in part due to reference product manufacturer tactics to delay biosimilar market entry and patent disputes.
In this study we examined whether lack of preferred coverage by commercial health insurers may also play a role.
Dr. Martin[/caption]
Sara Martin, MD, MSc
Santa Rosa Family Medicine Residency Program
Santa Rosa, California
MedicalResearch.com: What is the background for this study?
Response: To improve access to comprehensive primary care, we need to understand how much is being spent on primary care. Until recently, the United States lacked any data-based estimate of primary care expenditure. This study utilizes Medical Expenditure Panel Survey (MEPS)data from 2002 – 2016 to estimate the percentage of healthcare expenditures that was spent on primary care.
Most discussions around health care expenditure in the U.S. focus on the fact that we spend more than any other country and do not have the corresponding outcomes to match that investment. This paper focuses the conversation around the distribution of the expenditure.